Valuation : Sinotherapeutics Inc.

Market Cap 409.04Cr 61Cr 52Cr 49Cr 45Cr 84Cr 5.75TCr 85Cr 582.89Cr 226.19Cr 2.95TCr 228.79Cr 223.8Cr 9.51TCr P/E 2024
35.9x
P/E 2025 88.2x
Enterprise Value 334.4Cr 50Cr 43Cr 40Cr 37Cr 69Cr 4.7TCr 69Cr 476.52Cr 184.91Cr 2.41TCr 187.04Cr 182.96Cr 7.77TCr EV / Sales 2024
7.4x
EV / Sales 2025 8.08x
Free-Float
24.34%
Yield 2024
0.62%
Yield 2025 0.36%
1 day+0.11%
1 week-4.00%
Current month-0.65%
1 month+5.93%
3 months+14.45%
6 months-4.00%
Current year-6.08%
1 week 9.05
Extreme 9.05
9.41
1 month 8.38
Extreme 8.38
11.33
Current year 7.02
Extreme 7.02
11.33
1 year 7.02
Extreme 7.02
11.46
3 years 6.3
Extreme 6.3
14
5 years 6.3
Extreme 6.3
28
10 years 6.3
Extreme 6.3
28
Manager TitleAgeSince
Chief Executive Officer 53 06/04/2023
Director of Finance/CFO 57 30/04/2025
Investor Relations Contact 44 31/05/2023
Director TitleAgeSince
Chairman 53 18/08/2020
Director/Board Member 58 01/08/2012
Director/Board Member 44 01/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-4.00%-17.03%-16.42% 61Cr
-0.89%-1.09%+20.02%+71.25% 4.83TCr
-1.72%-1.15%+47.28%+115.51% 4.05TCr
-2.01%-5.96%+10.68%+80.50% 1.18TCr
-0.70%-2.70%-12.22%+11.80% 1.19TCr
+0.57%-0.56%+26.56%+154.33% 935.93Cr
-1.67%-0.35%+41.04%-12.04% 737.27Cr
+0.08%-4.11%+22.91%+43.56% 749.58Cr
-0.89%-3.09%+22.42%+220.05% 728.46Cr
-0.16%-2.36%-42.27%+15.39% 518.68Cr
Average -0.73%-1.97%+11.94%+68.39% 1.5TCr
Weighted average by Cap. -1.06%-1.72%+23.50%+83.90%

Financials

2024 2025
Net sales 51Cr 7.62Cr 6.56Cr 6.17Cr 5.64Cr 11Cr 719.51Cr 11Cr 73Cr 28Cr 369.16Cr 29Cr 28Cr 1.19TCr 45Cr 6.65Cr 5.72Cr 5.39Cr 4.92Cr 9.2Cr 628.03Cr 9.23Cr 64Cr 25Cr 322.22Cr 25Cr 24Cr 1.04TCr
Net income 13Cr 1.9Cr 1.64Cr 1.54Cr 1.41Cr 2.63Cr 179.59Cr 2.64Cr 18Cr 7.06Cr 92Cr 7.14Cr 6.99Cr 296.84Cr 4.75Cr 70.73L 60.86L 57.26L 52.31L 97.85L 67Cr 98.12L 6.77Cr 2.63Cr 34Cr 2.66Cr 2.6Cr 110.37Cr
Net Debt -73Cr -11Cr -9.4Cr -8.85Cr -8.08Cr -15Cr -1.03TCr -15Cr -104.53Cr -41Cr -529.27Cr -41Cr -40Cr -1.71TCr -75Cr -11Cr -9.57Cr -9Cr -8.22Cr -15Cr -1.05TCr -15Cr -106.37Cr -41Cr -538.58Cr -42Cr -41Cr -1.74TCr
Logo Sinotherapeutics Inc.
Sinotherapeutics Inc is a China-based company mainly engaged in the research and development, product registration, production and sales of generic drugs, as well as contract research organization/contract manufacture organization (CRO/CMO) services. The Company's main products include posaconazole enteric-coated tablets, mesalazine enteric-coated tablets, ursodeoxycholic acid capsules and others. The Company's products cover multiple fields including antifungal, psychiatric, diabetes, cancer, digestive, hypertension, nephrology, and analgesia. The Company's CRO/CMO services are primarily formulation CRO/CMO services, providing pharmaceutical companies and research institutions with specialized formulation development services during drug development and commercial manufacturing services after drug approval through contracts. The Company mainly conducts its business in the domestic and overseas markets.
Employees
319
Date Price Change Volume
04/26/04 CN¥9.110 +0.11% 40,44,649
03/26/03 CN¥9.100 -1.41% 29,59,928
02/26/02 CN¥9.230 -1.07% 36,17,222
01/26/01 CN¥9.330 +1.74% 57,51,044
31/26/31 CN¥9.170 -3.37% 64,37,158
  1. Stock Market
  2. Stocks
  3. 688247 Stock